Over-the-counter drug (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Over-the-counter drug" in English language version.

refsWebsite

Global rank English rank

16nih.gov

4^th place

13fda.gov

447^th place

338^th place

9doi.org

2^nd place

5web.archive.org

1^st place

2napra.ca

low place

1nridigital.com

low place

1overheid.nl

3,288^th place

4,712^th place

1princeton.edu

741^st place

577^th place

1usdoj.gov

2,755^th place

1,753^rd place

1nhs.uk

1,989^th place

1,528^th place

1mhra.gov.uk

low place

1europa.eu

68^th place

117^th place

1tga.gov.au

3,984^th place

2,622^nd place

1bbc.co.uk

8^th place

10^th place

bbc.co.uk

news.bbc.co.uk

"Over-the-counter Viagra piloted". BBC News Online. 11 February 2007. Retrieved 10 February 2009.

doi.org

Saha A, Balakrishnan S, Trivedi N, Abraham GM (1 January 2023). "Hypertension and Severe Hypokalemia Associated With Oral Ingestion of Topical Hydrocortisone Cream". AACE Clinical Case Reports. 9 (1): 2–4. doi:10.1016/j.aace.2022.10.004. PMC 9837079. PMID 36654996.
Sánchez-Sánchez E, Fernández-Cerezo FL, Díaz-Jimenez J, Rosety-Rodriguez M, Díaz AJ, Ordonez FJ, et al. (May 2021). "Consumption of over-the-Counter Drugs: Prevalence and Type of Drugs". International Journal of Environmental Research and Public Health. 18 (11): 5530. doi:10.3390/ijerph18115530. PMC 8196755. PMID 34064096.
Qato DM, Wilder J, Schumm LP, Gillet V, Alexander GC (April 2016). "Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011". JAMA Internal Medicine. 176 (4): 473–482. doi:10.1001/jamainternmed.2015.8581. PMC 5024734. PMID 26998708.
Esher A, Coutinho T (August 2017). "Rational use of medicines, pharmaceuticalization and uses of methylphenidate". Ciencia & Saude Coletiva (in Portuguese). 22 (8): 2571–2580. doi:10.1590/1413-81232017228.08622017. PMID 28793073.
Sánchez-Sánchez E, Fernández-Cerezo FL, Díaz-Jimenez J, Rosety-Rodriguez M, Díaz AJ, Ordonez FJ, et al. (May 2021). "Consumption of over-the-Counter Drugs: Prevalence and Type of Drugs". International Journal of Environmental Research and Public Health. 18 (11): 5530. doi:10.3390/ijerph18115530. PMC 8196755. PMID 34064096.
Saha A, Balakrishnan S, Trivedi N, Abraham GM (1 January 2023). "Hypertension and Severe Hypokalemia Associated With Oral Ingestion of Topical Hydrocortisone Cream". AACE Clinical Case Reports. 9 (1): 2–4. doi:10.1016/j.aace.2022.10.004. PMC 9837079. PMID 36654996.
Sánchez-Sánchez E, Fernández-Cerezo FL, Díaz-Jimenez J, Rosety-Rodriguez M, Díaz AJ, Ordonez FJ, et al. (May 2021). "Consumption of over-the-Counter Drugs: Prevalence and Type of Drugs". International Journal of Environmental Research and Public Health. 18 (11): 5530. doi:10.3390/ijerph18115530. PMC 8196755. PMID 34064096.
Sánchez-Sánchez E, Fernández-Cerezo FL, Díaz-Jimenez J, Rosety-Rodriguez M, Díaz AJ, Ordonez FJ, et al. (May 2021). "Consumption of over-the-Counter Drugs: Prevalence and Type of Drugs". International Journal of Environmental Research and Public Health. 18 (11): 5530. doi:10.3390/ijerph18115530. PMC 8196755. PMID 34064096.
Alexander GC, Mohajir N, Meltzer DO (2005). "Consumers' perceptions about risk of and access to nonprescription medications". Journal of the American Pharmacists Association. 45 (3): 363–370. doi:10.1331/1544345054003868. PMID 15991758.

europa.eu

ema.europa.eu

"Suspension of ranitidine medicines in the EU". European Medicines Agency (EMA) (Press release). 30 April 2020. Retrieved 2 June 2020.

fda.gov

"Over-the-Counter Medicines: What's Right for You?". FDA. Retrieved 19 May 2024.
"Understanding Over-the-Counter Medicines". Center for Drug Evaluation and Research. U.S. Food and Drug Administration. 14 August 2019. Retrieved 26 August 2019.
"Prescription Drugs and Over-the-Counter (OTC) Drugs: Questions and Answers". Center for Drug Evaluation and Research. U.S. Food and Drug Administration. 25 April 2019.
Drug Development and Review Definitions. Fda.gov (2015-08-20). Retrieved on 2019-08-26.
Drug Applications for Over-the-Counter (OTC) Drugs. Fda.gov (2015-01-07). Retrieved on 2019-08-26.
"Drug Applications for Over-the-Counter (OTC) Drugs". Center for Drug Evaluation and Research. U.S. Food and Drug Administration. 29 May 2019. Retrieved 26 August 2019.
Regulation of Nonprescription Drug Products Fda.gov. Retrieved on 2014-04-24.
OTC Drug Facts Label. Fda.gov (2015-06-05). Retrieved on 2019-08-26.
"An Exciting New Chapter in OTC Drug History: OTC Monograph Reform". U.S. Food and Drug Administration (FDA). 6 August 2020. Retrieved 2 September 2020. This article incorporates text from this source, which is in the public domain.
Over-the-Counter Monograph User Fee Program Performance Goals and Procedures - Fiscal Years 2018-2022 (PDF) (Report). U.S. Food and Drug Administration (FDA). Retrieved 2 September 2020. This article incorporates text from this source, which is in the public domain.
"Phenylpropanolamine (PPA) Information Page". Center for Drug Evaluation and Research. U.S. Food and Drug Administration. 22 December 2005.
"Questions and Answers: NDMA impurities in ranitidine (commonly known as Zantac)". U.S. Food and Drug Administration. 11 October 2019. Archived from the original on 24 October 2019. Retrieved 23 October 2019. This article incorporates text from this source, which is in the public domain.
"FDA Requests Removal of All Ranitidine Products (Zantac) from the Market". U.S. Food and Drug Administration (FDA) (Press release). 1 April 2020. Retrieved 1 April 2020. This article incorporates text from this source, which is in the public domain.

mhra.gov.uk

"Availability of medicines". Archived 2010-03-29 at the Wayback Machine. MHRA. Retrieved on 2012-07-04.

napra.ca

"NDS Process and Scheduling Factors". National Association of Pharmacy Regulatory Authorities. Retrieved 26 August 2019.
"Drug Scheduling in Canada". National Association of Pharmacy Regulatory Authorities. Retrieved 26 August 2019.

nhs.uk

"Medicines information". NHS Choices. Retrieved 19 September 2017.

nih.gov

pubmed.ncbi.nlm.nih.gov

Saha A, Balakrishnan S, Trivedi N, Abraham GM (1 January 2023). "Hypertension and Severe Hypokalemia Associated With Oral Ingestion of Topical Hydrocortisone Cream". AACE Clinical Case Reports. 9 (1): 2–4. doi:10.1016/j.aace.2022.10.004. PMC 9837079. PMID 36654996.
Sánchez-Sánchez E, Fernández-Cerezo FL, Díaz-Jimenez J, Rosety-Rodriguez M, Díaz AJ, Ordonez FJ, et al. (May 2021). "Consumption of over-the-Counter Drugs: Prevalence and Type of Drugs". International Journal of Environmental Research and Public Health. 18 (11): 5530. doi:10.3390/ijerph18115530. PMC 8196755. PMID 34064096.
Qato DM, Wilder J, Schumm LP, Gillet V, Alexander GC (April 2016). "Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011". JAMA Internal Medicine. 176 (4): 473–482. doi:10.1001/jamainternmed.2015.8581. PMC 5024734. PMID 26998708.
Esher A, Coutinho T (August 2017). "Rational use of medicines, pharmaceuticalization and uses of methylphenidate". Ciencia & Saude Coletiva (in Portuguese). 22 (8): 2571–2580. doi:10.1590/1413-81232017228.08622017. PMID 28793073.
Sánchez-Sánchez E, Fernández-Cerezo FL, Díaz-Jimenez J, Rosety-Rodriguez M, Díaz AJ, Ordonez FJ, et al. (May 2021). "Consumption of over-the-Counter Drugs: Prevalence and Type of Drugs". International Journal of Environmental Research and Public Health. 18 (11): 5530. doi:10.3390/ijerph18115530. PMC 8196755. PMID 34064096.
Saha A, Balakrishnan S, Trivedi N, Abraham GM (1 January 2023). "Hypertension and Severe Hypokalemia Associated With Oral Ingestion of Topical Hydrocortisone Cream". AACE Clinical Case Reports. 9 (1): 2–4. doi:10.1016/j.aace.2022.10.004. PMC 9837079. PMID 36654996.
Sánchez-Sánchez E, Fernández-Cerezo FL, Díaz-Jimenez J, Rosety-Rodriguez M, Díaz AJ, Ordonez FJ, et al. (May 2021). "Consumption of over-the-Counter Drugs: Prevalence and Type of Drugs". International Journal of Environmental Research and Public Health. 18 (11): 5530. doi:10.3390/ijerph18115530. PMC 8196755. PMID 34064096.
Sánchez-Sánchez E, Fernández-Cerezo FL, Díaz-Jimenez J, Rosety-Rodriguez M, Díaz AJ, Ordonez FJ, et al. (May 2021). "Consumption of over-the-Counter Drugs: Prevalence and Type of Drugs". International Journal of Environmental Research and Public Health. 18 (11): 5530. doi:10.3390/ijerph18115530. PMC 8196755. PMID 34064096.
Alexander GC, Mohajir N, Meltzer DO (2005). "Consumers' perceptions about risk of and access to nonprescription medications". Journal of the American Pharmacists Association. 45 (3): 363–370. doi:10.1331/1544345054003868. PMID 15991758.

ncbi.nlm.nih.gov

Saha A, Balakrishnan S, Trivedi N, Abraham GM (1 January 2023). "Hypertension and Severe Hypokalemia Associated With Oral Ingestion of Topical Hydrocortisone Cream". AACE Clinical Case Reports. 9 (1): 2–4. doi:10.1016/j.aace.2022.10.004. PMC 9837079. PMID 36654996.
Sánchez-Sánchez E, Fernández-Cerezo FL, Díaz-Jimenez J, Rosety-Rodriguez M, Díaz AJ, Ordonez FJ, et al. (May 2021). "Consumption of over-the-Counter Drugs: Prevalence and Type of Drugs". International Journal of Environmental Research and Public Health. 18 (11): 5530. doi:10.3390/ijerph18115530. PMC 8196755. PMID 34064096.
Qato DM, Wilder J, Schumm LP, Gillet V, Alexander GC (April 2016). "Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011". JAMA Internal Medicine. 176 (4): 473–482. doi:10.1001/jamainternmed.2015.8581. PMC 5024734. PMID 26998708.
Sánchez-Sánchez E, Fernández-Cerezo FL, Díaz-Jimenez J, Rosety-Rodriguez M, Díaz AJ, Ordonez FJ, et al. (May 2021). "Consumption of over-the-Counter Drugs: Prevalence and Type of Drugs". International Journal of Environmental Research and Public Health. 18 (11): 5530. doi:10.3390/ijerph18115530. PMC 8196755. PMID 34064096.
Saha A, Balakrishnan S, Trivedi N, Abraham GM (1 January 2023). "Hypertension and Severe Hypokalemia Associated With Oral Ingestion of Topical Hydrocortisone Cream". AACE Clinical Case Reports. 9 (1): 2–4. doi:10.1016/j.aace.2022.10.004. PMC 9837079. PMID 36654996.
Sánchez-Sánchez E, Fernández-Cerezo FL, Díaz-Jimenez J, Rosety-Rodriguez M, Díaz AJ, Ordonez FJ, et al. (May 2021). "Consumption of over-the-Counter Drugs: Prevalence and Type of Drugs". International Journal of Environmental Research and Public Health. 18 (11): 5530. doi:10.3390/ijerph18115530. PMC 8196755. PMID 34064096.
Sánchez-Sánchez E, Fernández-Cerezo FL, Díaz-Jimenez J, Rosety-Rodriguez M, Díaz AJ, Ordonez FJ, et al. (May 2021). "Consumption of over-the-Counter Drugs: Prevalence and Type of Drugs". International Journal of Environmental Research and Public Health. 18 (11): 5530. doi:10.3390/ijerph18115530. PMC 8196755. PMID 34064096.

nridigital.com

Millar A (February 2018). "Defining OTC Drugs". Pharma Technology Focus (67). Retrieved 3 February 2018.

overheid.nl

wetten.overheid.nl

Geneesmiddelenwet^{[full citation needed]}

princeton.edu

ec.princeton.edu

"Princeton University". Archived from the original on 19 April 2021. Retrieved 4 February 2020.

tga.gov.au

"Ranitidine". Therapeutic Goods Administration (TGA). 2 April 2020. Archived from the original on 29 August 2021. Retrieved 19 July 2020.

usdoj.gov

deadiversion.usdoj.gov

Controlled Substances Listed in Schedules III, IV, and V Archived 2021-03-21 at the Wayback Machine. US Department of Justice - Drug Enforcement Administration. Retrieved on 2019-08-26.

web.archive.org

"Princeton University". Archived from the original on 19 April 2021. Retrieved 4 February 2020.
Controlled Substances Listed in Schedules III, IV, and V Archived 2021-03-21 at the Wayback Machine. US Department of Justice - Drug Enforcement Administration. Retrieved on 2019-08-26.
"Availability of medicines". Archived 2010-03-29 at the Wayback Machine. MHRA. Retrieved on 2012-07-04.
"Questions and Answers: NDMA impurities in ranitidine (commonly known as Zantac)". U.S. Food and Drug Administration. 11 October 2019. Archived from the original on 24 October 2019. Retrieved 23 October 2019. This article incorporates text from this source, which is in the public domain.
"Ranitidine". Therapeutic Goods Administration (TGA). 2 April 2020. Archived from the original on 29 August 2021. Retrieved 19 July 2020.